High-dose Bevacizumab in Advanced Renal Carcinoma Patients
Part of paid clinical trials in Fort Myers, Florida.
- Sponsor
- SCRI Development Innovations, LLC
- Study ID
- NCT00455975
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab — DRUGBevacizumab
Study Details
This trial will examine the effectiveness and the side effects of 2 higher dosing schedules of bevacizumab in patients that have advanced clear cell renal carcinoma.
Key Dates
- First listed
- Apr 4, 2007
- Start date
- Feb 28, 2007
- Status verified
- Dec 2014
- Primary completion
- Jul 31, 2013
- Completion
- Sep 30, 2013
Study Design
- Enrollment
- 119 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Weekly AvastinBevacizumab 15mg/kg IV weekly until progressive disease or toxicity
- Experimental: Bi-weekly AvastinBevacizumab 15mg/kg IV every 2 weeks until progressive disease or toxicity
Primary Outcome Measure
Progression-free Survival [ Time Frame: 18 months (expected) ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | - |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | - |
| Consultants in Blood Disorders and Cancer | Louisville | Kentucky | 40207 | - |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | - |
| Methodist Cancer Center | Omaha | Nebraska | 68114 | - |
| Cancer Care of Western North Carolina | Asheville | North Carolina | 28801 | - |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | - |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | - |
| Spartanburg Regional Medical Center | Spartanburg | South Carolina | 29303 | - |
| Chattanooga Oncology Hematology Associates | Chattanooga | Tennessee | 37404 | - |
| Family Cancer Center | Collierville | Tennessee | 38017 | - |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37023 | - |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | - |
Find similar trials in Fort Myers, FL
By condition
By research site
Related Studies
- Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant DiseaseRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland